U.S. authorizes Merck pill to fight COVID-19

December 23rd, 20210 WASHINGTON D.C. — Just one day after authorizing Pfizer's Paxlovid pill for at-home use, health regulators have authorized a second pill to combat COVID-19. The Food and Drug Administration (FDA) has authorized Merck’s molnupiravir, although Pfizer’s Paxlovid is likely to become the first-choice treatment due to having milder...